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Abstract
Background: Bone marrow stromal cells and radial glia are two stem cell types with neural
phenotypic plasticity. Bone marrow mesenchymal stem cells can differentiate into osteocytes,
chondrocytes and adipocytes, but can also differentiate into non-mesenchymal cell, i.e. neural cells
in appropriate in vivo and  in vitro experimental conditions. Likewise, radial glial cells are the
progenitors of many neurons in the developing cortex, but can also generate astrocytes. Both cell
types express nestin, an intermediate filament protein which is the hallmark of neural precursors.
Results: In this study, we demonstrate that thrombin, a multifunctional serine protease, stimulates
the growth of radial glial cells (RG) and mesenchymal stem cells (MSCs) in a dose-dependent
manner. In RG, the mitogenic effect of thrombin is correlated with increased expression of nestin
but in MSCs, this mitogenic effect is associated with nestin down-regulation. Both cell types express
the PAR-1 type receptor for Thrombin and the effect of Thrombin on both cell types can be
mimicked by its analogue TRAP-6 activating specifically this receptor subtype or by serum which
contains various amount of thrombin. Moreover, we also demonstrate that serum deprivation-
induced expression of nestin in MSCs is inhibited by high cell density (> 50,000 cells/cm2).
Conclusion: This work shows that thrombin stimulates the growth of both RG and MSCs and that
nestin expression by MSCs and RG is regulated in opposite manner by thrombin in vitro. Thrombin
effect is thus associated in both cell types with a proliferating, undifferentiated state but in RG this
involves the induction of nestin expression, a marker of immaturity for neural progenitors. In MSCs
however, nestin expression, as it corresponds to a progression from the mesenchymal
"undifferentiated", proliferating phenotype toward acquisition of a neural fate, is inhibited by the
mitogenic signal.
Background
Stem cells have the capacity to self-replicate or to produce
progeny of one or several specific differentiated cell types.
There are two types of stem cells: embryonic and somatic
stem cells, which are found in foetal and adult tissue
respectively. While they are generally committed to a par-
Published: 30 November 2007
BMC Neuroscience 2007, 8:104 doi:10.1186/1471-2202-8-104
Received: 2 August 2007
Accepted: 30 November 2007
This article is available from: http://www.biomedcentral.com/1471-2202/8/104
© 2007 Wautier et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Neuroscience 2007, 8:104 http://www.biomedcentral.com/1471-2202/8/104
Page 2 of 11
(page number not for citation purposes)
ticular tissue fate, somatic stem cells can alternatively gen-
erate cells belonging to different tissue types when they
are exposed to specific cues produced by a different tissue.
High hopes rest on the future application of stem cells in
cellular therapies, including those of the central nervous
system disorders. For this reason, the mechanisms that
regulate the acquisition of a neural fate by somatic stem
cells are under intensive study. In this work, we will
extend our investigations of the regulation of the expres-
sion of nestin, a neural stem cell marker, by mesenchymal
stem cells (MSCs) and compare it to the corresponding
process occurring in radial glial cells (RG), a major form
of neural stem cell in mammalian central nervous system
(CNS) development.
MSCs can differentiate into many types of mesenchymal
phenotypes, i.e. osteocytes, chondrocytes and adipocytes,
and they can also differentiate into non-mesenchymal
cell, i.e. neural cells, when grafted in the lesioned central
nervous system [1,2] or when grown in vitro together with
neural cells [3-5]. In the latter case, MSCs adopt a neural
fate in co-culture only after expressing nestin, an interme-
diate filament protein which is predominantly expressed
during early stages of development by stem and progeni-
tor cells of the central nervous system [3-6]. In cultivated
MSCs, nestin expression requires serum-free conditions
and at least 25 cell population doublings (corresponding
to 10 cell passagings) to occur, suggesting a kind of matu-
ration and/or selection of rat nestin-positive neurogenic
MSCs [5].
During development, the CNS of vertebrates contains an
abundant cell type designated as radial glial cells (RG).
These cells while classically known as guiding cues for
migrating neurons [7], play a major role as precursor cells
for pyramidal neurons and astrocytes [8-11]. Since RG
express a number of astroglial characteristics and can dif-
ferentiate into astrocytes after completing their guidance
function, they have been previously considered as integral
part of the glial lineage. However, it was recently demon-
strated that RG may persist as neural stem cells in several
discrete regions of the adult brain. RG are expressing nes-
tin both in vivo and in vitro [12] as well as an antigen
related to nestin and recognized by the RC2 antibody
[13]. While several growth factors and activities are
known to act on the proliferation and differentiation of
RG [7], their phenotype is also controlled in vitro by fac-
tors contained in serum [13]. Indeed, the transition
between RC2-positive RG and stellate GFAP-positive
astrocytes and its reversal can be induced, respectively, by
withdrawal and addition of serum in the growth medium
of cultures of developing cerebellar glial cells. In the case
of MSCs, it is the withdrawal of serum that allows their
expression of nestin suggesting that some serum-derived
factors inhibit nestin expression in these cells.
Because serum-dependent effects on the stellation of
astrocytes have been attributed to thrombin which is a
normal serum component [14], we addressed the ques-
tion of the regulation by thrombin of nestin expression in
both MSCs and RG. Indeed there are indications that
thrombin can have a regulatory role in nestin expression
in vivo after experimental intracerebral haemorrhage [15].
We demonstrate that the presence of thrombin in the cul-
ture medium stimulates the growth of both RG and MSCs
in a dose-dependent manner. In addition to the mitogenic
effect, we demonstrate that thrombin represses nestin
expression by MSCs but increases its expression by RG. We
found that the PAR-1 receptor is involved in the regula-
tion of nestin expression by both cell types to thrombin.
Finally, we demonstrate that the modulation of nestin-
expression by MSCs in serum-free conditions is depend-
ent on their cell density.
Results
Serum and thrombin mitogenic effect on Radial Glia and 
Mesenchymal stem cells
To measure the effect of serum and thrombin on the pro-
liferation of MSCs and RG, cells that had been maintained
in serum-free conditions were allowed to incorporate
BrdU in the presence of serum or thrombin (Table 1). An
increase of the BrdU labelling index was observed for both
MSCs and RG that were treated with serum or thrombin.
While RG did not incorporate BrdU in the absence of
serum, addition of thrombin at 2 nM stimulated their
BrdU incorporation to 28% of that induced by serum.
With MSCs, about 80% of all cells were incorporating
BrdU in serum-free medium and addition of either serum
or 900 pM thrombin to the medium lead to similar
increases of labelling indexes up to 88 and 90% of all
cells.
We used a double immunostaining procedure for nestin
and BrdU to analyze separately the BrdU incorporation by
both nestin-positive and nestin-negative MSCs (Table 1).
We found that 86% of nestin- positive MSCs incorporated
BrdU and that this percentage did not change significantly
after addition of serum or thrombin. Contrasting with
this, we found that 68.8% of nestin-negative MSCs incor-
porated BrdU in the absence of serum and that this per-
centage increased significantly in the presence of
thrombin and serum (p < 0.01, n = 3, 4000 counted cells)
to reach values close to those of nestin-positive cells.
Regulation of nestin expression by thrombin in Radial Glia 
and in Mesenchymal stem cells
MSCs and mouse RG production of nestin was assessed by
immunostaining, leading to the conclusion that
thrombin regulates nestin expression differently in the
two cell types (Figure 1 and 2). A decrease in the number
of nestin-positive MSCs was observed when, after 72BMC Neuroscience 2007, 8:104 http://www.biomedcentral.com/1471-2202/8/104
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hours in serum-free culture medium allowing them to
express nestin, they were grown further for 3 days in the
presence of serum or thrombin (Fig. 1A–C). This effect of
thrombin was dose-dependent with half-inhibition occur-
ring at 180 pM thrombin (Fig. 1C).
TRAP is a hexapeptide that corresponds to amino acids 42
to 47 of the thrombin receptor and mimics the effect of
thrombin independently of receptor cleavage [16]. When
MSCs were incubated in DEM supplemented with differ-
ent concentrations of TRAP6, a significant decrease of nes-
tin-positive MSCs number occurred at concentration of
TRAP6 equal to or above 1 μM (*, p < 0.05, Fig. 1G).
Those immunocytofluorescence observations were con-
firmed by a Western blotting approach. In immunoblots,
the signal for nestin was observed in each condition but
decreased in the presence of serum or thrombin while the
signal obtained for actin remained unchanged (Fig. 1D,
E).
In order to exclude an apoptotic effect of thrombin on
MSCs that would lead to a specific decrease of the number
of nestin-positive cells, we performed a TUNEL assay on
MSCs treated with different concentrations of thrombin.
No apoptotic cells were found in any condition, while a
positive control, in which MSCs were treated by DNAse,
showed a strong TUNEL labelling (Fig 1H,I).
An indirect effect of thrombin that would regulate nestin
expression through an increase in cell density and cell to
cell interactions can also be excluded. Although thrombin
induces a proliferative effect on rMSC, no change in cell
density occurred in cultures treated with increasing con-
centrations of thrombin for 3 days (Fig 1J). When, FUdR
(10-5 M) was added to inhibit DNA synthesis and cell pro-
liferation, a significant decrease of nestin expression by
rMSC cultivated in DEM + 900 pM thrombin or 10%
serum was still observed indicating that thrombin inhibits
directly nestin expression by rMSC (Fig 1K).
An opposite effect was seen with radial glial cells which
stop expressing nestin after 48 hours without serum but
maintain this expression in the presence of serum,
thrombin or TRAP-6 (Fig. 2A–D). No such effect was seen
on GFAP expression which was not investigated further.
Western-blot analysis allowed to estimate at respectively
300 pM and 10 μM the concentrations of thrombin and
TRAP-6 causing a half-maximal stimulation of nestin
expression (Fig. 2E,F).
Because MSCs and RG were obtained from different
rodent species and are usually grown in the presence of
different sera, the effect of horse serum instead of bovine
serum was tested on rat MSCs and the same experiment
was repeated with mouse MSCs. No significant difference
was found when nestin-positive rat MSCs were treated
with DEM+10% FBS and MEM+10%HS, the medium
used for RG cultivation (Fig. 1L), suggesting that FBS and
HS exert the same effect on nestin expression of rat MSCs.
A similar effect was observed when mouse MSCs (after 25
cell population doublings) were tested (Fig 1E), suggest-
ing that the species difference between rat MSCs and
mouse RG is not responsible for the observed different
regulation of nestin expression by serum and thrombin.
Thrombin receptor in Radial Glia and Mesenchymal Stem 
Cells
The presence of the specific Thrombin receptor PAR-1 was
demonstrated on both RG cells and MSCs by immunocy-
tochemistry using the H-111 antibody. In both cell types
PAR-1 is expressed by cells grown in the presence or
absence of serum (Fig. 3). The distribution of PAR-1 is
indicative of a plasma membrane localization as it
extends frequently to cell processes that the intermediate
filaments Nestin or GFAP did not reach (Fig. 3A,B). More
intense staining was also visible in the nucleus.
In MSCs, we observed by double-immunocytochemistry,
the expression of PAR1 on both nestin-negative and nes-
Table 1: Effect of serum and Thrombin on the proliferation of radial glia and rat MSCs
- serum + serum + Thrombin
RG (n = 3) 1.8 +/- 1.62 43.73 +/- 3.95 (**) 12.2 +/- 3.22 (*)
MSCs (P10): all cells (n = 3) 79.9 +/- 0.35 88.5 +/- 0.23 (**) 90.4 +/- 2.29 (**)
Nestin-negative MSCs (n = 3) 68.8 +/- 0.74 84.7 +/- 1.54 (**) 83.2 +/- 2.21 (**)
Nestin-positive MSCs (n = 3) 86.0 +/- 4.9 92.0 +/- 8.9 (ns) 89.6 +/- 1.06 (ns)
Ns: no significant difference.
*: p < 0,05.
** p < 0,01.
RG and rat MSCs were cultured for respectively 2 and 3 days in the absence of serum and then were grown for two further days in the presence of 
serum or with 2 nM (RG) or 900 pM (rat MSCs) of thrombin. BrdU (20 μM) was added for the last 18 hrs before fixation with paraformaldehyde 
and immunofluorescent staining for both nestin and BrdU incorporation. Cells were counted on 10 microscopic fields (40×) on at least three 
coverslips in each condition. Percentage of BrdU-incorporating cells and standard deviation in each condition, obtained with GraphPad Prism4 
Software, are shown. Levels of significance compared to the control (- serum) condition are shown.BMC Neuroscience 2007, 8:104 http://www.biomedcentral.com/1471-2202/8/104
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Repression of nestin expression in rat MSCs cultures by serum, thrombin and TRAP6 Figure 1
Repression of nestin expression in rat MSCs cultures by serum, thrombin and TRAP6. Rat MSCs and mouse MSCs of at least 25 population 
doublings were cultured for 3 days in serum-free medium to induce nestin expression. Then, the cells were renewed in DEM supplemented with different 
concentrations of thrombin (0 (A, rat MSCs), 90, 180, 450 (B, rat MSCs) and 900 pM), in DEM + 10% FBS or MEM + 10% horse serum (L) or in DEM + 900 
pM of thrombin with 10-5M of FUdR (K) for a further 3 days period and then fixed and labelled with anti-nestin antibody (green). Nuclei were counter-
stained with TOPRO-3 (red) and then counted. In these conditions, there is a significant decrease of nestin expression both in rat MSCs (C) with 180 pM 
(*, p < 0,05), 450 and 900 pM of thrombin (**, p < 0,01) and in mouse MSCs (F) from 180 pM of thrombin (**). (L) There is however no difference when 
HS in MEM (18% of cell expressing nestin) is used instead of FBS in DEM (10% of cell expressing nestin). These results were confirmed by Western blotting 
(D), where nestin expression in rat MSCs cultivated in DEM, DEM + 1 nM of thrombin and DEM + 10% FBS was compared after 3 days of induction of nes-
tin expression. The actin immunostaining controls the amount of protein loaded on the gel in each condition and allows to calculate the ratio between the 
intensity of the nestin and actin signals and to normalize data to the level of nestin expression in rat MSCs treated with DEM only (E). Rat MSCs were cul-
tured for 3 days in serum-free medium to induce nestin expression. Then, those cells were renewed in DEM supplemented with different concentration of 
TRAP6, for a further 3 days period and then fixed and labelled with nestin antibody. Nuclei counterstained with TOPRO-3 and nestin-positive MSCs were 
then counted. (G) In these conditions, there is a significant decrease of nestin expression from 1 μM TRAP6 (*, p < 0,05; **, p < 0,01 from 30 μM, n = 3, 
ANOVA1). (H) To measure the effect of thrombin on the apoptosis of rat MSCs, cells were cultivated for 3 days in serum-free medium to induce nestin 
expression. Then, those cells were renewed in DEM with various concentrations of thrombin. After a new 3 days period, cells were fixed and submitted 
to a TUNEL labelling (green). Cell nuclei were counterstained with DAPI. For the positive control of the TUNEL assay, rat MSCs previously treated with 
DNAse were used (I). (J) To measure the effect of thrombin on cell density, cells were treated with the indicated concentrations of thrombin, then fixed, 
labelled with DAPI and counted in 10 microscopic fields at 10× magnification. Scale bar in A, B, H, I = 40 μm.
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tin-positive MSCs suggesting that both cell types might be
sensitive to the effect of thrombin (Fig. 3E–F).
To confirm the expression of PAR1 by MSCs and RG cells,
RT-PCR analysis was performed on total RNA extracts of
both cell types. Using primers optimized for rat and
mouse transcripts, PAR1 mRNA was detected in mouse
RG (Fig 3G) and in MSCs (Fig. 3H) at a level comparable
to that of astrocytes of rat used as positive control.
GAPDH mRNA served as internal control of the RT-PCR.
Regulation of nestin expression by density of 
Mesenchymal stem cells
We have noticed that the effect of omitting serum in cul-
tures of MSCs in order to increase their expression of nes-
tin is variable in efficacy and that this variation could be a
consequence of differing densities of MSCs stimulated by
serum withdrawal. In order to determine how cell density
could regulate the expression of nestin by MSCs, cells were
plated at various densities in growth medium without
serum for 3 days to induce nestin expression (Fig. 4A, B).
We observed that at a density of 50,000 cells/cm2 or
above, MSCs decrease by more than 8-fold their nestin
expression in response to serum withdrawal (Fig. 4C).
Those results were confirmed by Western blot on cultures
established at a density of 20, 50 or 100·103 MSCs/cm2
which reached about 70, 90 and 100% confluence before
extraction as shown by phase contrast microscopy (Fig
4D–F). Using identical amounts of total protein extracted
from MSCs plated in serum-free conditions, nestin signal
decreases with increasing cellular density (Fig. 4G). Quan-
tification of the nestin expression in each condition was
determined by calculating the ratio between the intensity
of the nestin bands and the corresponding actin signals
Stimulation of nestin expression in RG cultures by thrombin and TRAP6 Figure 2
Stimulation of nestin expression in RG cultures by thrombin and TRAP6. RG were cultured for 2 days in the presence of serum (A) or were 
maintained for the same time in serum-free medium to suppress their nestin expression (B), or in serum-free medium plus 900 pM Thrombin (C) or 100 
μM TRAP6 (D). Then, the cells were fixed and labelled with anti-nestin (green) and anti-GFAP (red) antibody. Nuclei were counterstained with TOPRO-3 
(blue). In the presence of thrombin or TRAP6, the expression of nestin is maintained together with that of GFAP which is co-expressed in a varying pro-
portion of the cells. Additional cell cultures that were treated in parallel with varying concentrations of thrombin (90 to 900 pM, E) or TRAP6 (0.3 to 100 
μM, F) were collected and total protein extracts were prepared. Nestin concentrations in those extracts was then measured by Western blots as 
described in Material and Methods. Scale bar (in A = 40 μm) applies to all images.
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used as internal control for the protein contents loaded on
the gel. This was normalized to the level of nestin expres-
sion in MSCs seeded at 20·103 cells/cm2 (Fig 4H).
To further characterize the mechanism (soluble factor ver-
sus membrane-bound factor) responsible for such an
effect, we co-cultivated MSCs coated on coverslips at a per-
missive density for 48 hours in serum-free medium
together with different densities of MSCs physically sepa-
rated in a millicell device (Fig. 4I). No significant decrease
in nestin expression is observed in the MSCs grown at a
permissive density on coverslips (n = 3, ANOVA-1 test, p
> 0.05) in the presence of a high density of MSCs in a mil-
licell. This clearly suggests that the decrease of nestin
expression at high MSCs cell density requires a direct cell-
to-cell contact. As a positive control of the permeability of
the millicell device in such setup, MSCs were cultivated at
a permissive density in serum-free medium with 30% FBS
loaded into a millicell device. A strong decrease of nestin
expression was indeed observed under this condition.
Discussion
Thrombin, a multifunctional serine protease, plays central
functions in haemostasis but also promotes a wide range
of cellular responses via an interaction with specific seven-
transmembrane domains receptors [17]. Thrombin and
perhaps other coagulant proteases, mediates proliferative
responses triggered by tissue damage [18-20]. In vitro,
thrombin is the most potent activator of blood platelets
[21,22], is chemotactic for monocytes [21,23], and is a
potent mitogenic factor for vascular smooth-muscle
cells[24], fibroblasts [21,25] and vascular endothelial
cells [26,27]. Thrombin signalling is mediated by a family
of G protein-coupled protease-activated receptors (PARs),
for which PAR1 is the prototype [17]. Thrombin activates
PAR1 through binding to and subsequent cleavage of the
N-terminal domain of the receptor to expose a new
amino-terminus that then acts as a tethered ligand to ini-
tiate intracellular signalling by the receptor [17]. We
found on both radial glial cells and rat MSCs a membra-
nous expression of PAR1 suggesting that thrombin may
Expression of the PAR1 thrombin receptor in RG and rat MSCs cultures Figure 3
Expression of the PAR1 thrombin receptor in RG and rat MSCs cultures. RG and rat MSCs were cultured for 2 days in the presence of serum 
(A, B, E) or were maintained for the same time in serum-free medium (C, D, F). Then, the cells were fixed and RG were labelled with anti-nestin (green), 
anti-PAR1 (red) and anti-GFAP (blue) antibody (panel A-D) while rat MSCs were stained with anti-nestin (green) and anti-PAR1 (red) antibody (panel E, F). 
Scale bar (in A = 10 μm) applies to all images. Expression of thrombin receptor PAR1mRNA in mouse RG (G) and rat MSCs and astrocytes (H) was ana-
lyzed by RT-PCR using optimized primers for each species.
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act on these cells physiology. We also found that PAR1 is
expressed in the nucleus and cytoplasm. The intracellular
staining for PAR1 can be explained by the presence of
intracellular store of PAR1 in the cells [28].
There is increasing evidence suggesting that members of
the serine protease family, including thrombin, chymot-
rypsin, urokinase plasminogen activator, and kallikrein,
may play a role in normal development and/or pathology
of the nervous system. Thrombin-like proteases have been
shown to exert deleterious effects on different neuronal
and non-neuronal cell populations in vitro, including neu-
rite retraction and death [29-31]. Moreover, the proteo-
lytic activity of thrombin has been shown to inhibit long-
term morphological differentiation in serum-free cultures
of several cell types, including spinal cord and brain neu-
rons, neuroblastoma cells, astroglial and neuroepithelial
cells [32-35].
Nestin expression in the adult nervous system has been
detected in a number of pathological conditions includ-
ing cerebral ischemia [36-38]., and traumatic brain injury
[39]. Nakamura et al.[15] have demonstrated that intrac-
erebral injections of low doses of thrombin that induces
Cell density regulation of nestin expression by rat MSCs in culture Figure 4
Cell density regulation of nestin expression by rat MSCs in culture. Rat MSCs were seeded at different cell densities (2.5 to 100·103 rMSCs/cm2) 
and maintained during 3 days in serum-free medium. These cells were then fixed, labelled with anti-nestin antibody (green), counterstained with TOPRO-
3 (red) and positive cells were counted in triplicate cultures. A and B show typical results of anti-nestin immunostaining in culture seeded at initial densities 
of 20 and 50·103 cells/cm2. From 50000 rMSC/cm2, nestin expression decreases rapidly (C). In this experiment, results are expressed as percentages of 
nestin-positive cells in each culture conditions (n = 3, ANOVA1). These results were confirmed by Western blotting analysis. Rat MSCs were plated dur-
ing 3 days in serum-free medium at different densities (20 (D), 50 (E) or 100 (F)·103 cells/cm2) and representative images were taken with a phase contrast 
microscope. Protein extracts were separated and revealed with anti-nestin and anti-actin antibodies. A decrease of nestin expression is apparent from an 
initial density of 50·103 cells/cm2 (G). Actin immunostaining controls the protein amounts loaded on the gel in each condition (H). Rat MSCs were culti-
vated at a density of 10,000 rat MSCs/cm2 together with different densities of rat MSCs in a physically separated millicell co-culture device. No significant 
difference was observed when the proportion of rat MSCs immunolabelled for nestin was compared in each condition (I) (n = 3, ANOVA1). Serum added 
in a millicell device as a positive control strongly inhibits nestin expression by rMSCs in the same setup. Scale bar A, B, D, E, F = 40 μm.
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neuroprotection without causing detectable brain injury
resulted in a marked increase in nestin expression indicat-
ing that this could constitute a protective mechanism
induced in astrocytes by levels of stress that do not pro-
duce a definable lesion. Nestin expression could, there-
fore, represent an embryonic reversion of the mature
cytoskeleton that may aid in the response to and recovery
from a wide variety of cerebral injuries, but might also
perhaps aid in damage prevention.
In this study, we demonstrate that nestin expression is reg-
ulated by thrombin in opposite manner in RG and MSCs
although the proliferation of both cell types is stimulated
by this protease. Thrombin effect is thus associated in
both cell types with a proliferating, undifferentiated state
but in RG cells this involves the induction of nestin
expression, a marker of immaturity for neural progenitors.
In MSCs however, nestin expression corresponds to the
first step toward acquisition of a neural fate and thus cor-
responds to a progression from the mesenchymal "undif-
ferentiated", proliferating phenotype [3-5]. Maintenance
of MSCs proliferation in the presence of thrombin would
indeed be associated with an inhibition of nestin expres-
sion by MSCs as it constitutes one feature of their undif-
ferentiated state. A possible selection of one population
type over the other can be discounted as an explanation
for the decrease of nestin expression by MSCs in the pres-
ence of thrombin because this effect still occurs in cells
that cannot proliferate when treated with FUdR. Further-
more, the absence of apoptotic cells in the cultures treated
with thrombin as well as the similar proliferation rates for
both nestin-negative and nestin-positive MSCs which are
induced in the presence of serum or thrombin in the
growth medium demonstrate that thrombin represses
directly the expression of nestin by MSCs and does not act
by selecting the population of nestin-negative cells.
Thus unlike radial glial cells, MSCs in vitro respond to
thrombin by a decrease of nestin expression. The nestin
gene contains two tissue-specific transcriptional elements
: a cis-element in the first intron drives nestin expression
in somitic muscle precursors, while an enhancer in the
second intron directs expression to CNS precursor cells
[40] and thus to radial glial cells. Which of these two reg-
ulatory elements controls nestin expression by MSCs
remains to be determined.
Finally, we demonstrate that nestin expression by MSCs
decreases at a high cell density, as observed by immuno-
cytofluorescence and Western blot assay. Tropepe et
al.[41] have found that embryonic stem cells express nes-
tin when they differentiate into neural cells. This expres-
sion and the subsequent neural differentiation of
embryonic stem cells are inhibited by a high cell density
suggesting a similar behaviour for both MSCs and embry-
onic stem cells. It has also been demonstrated that a high
cell density could accelerate the differentiation of human
bone marrow MSCs into chondrocyte in a chondrogenic
differentiation medium [42]. However, this chondrogenic
differentiation is mediated by soluble factors while the
decrease of nestin expression observed in our experiments
is mediated by a direct cell-to-cell contact. Since our exper-
iments were made with MSCs obtained after more than 10
passages, we cannot exclude that these apparently differ-
ent regulatory processes for the high cell density effect on
MSCs mesodermal fate result from the use of MSCs of
early and late passages.
There are however indications that MSCs of late passage
secrete a soluble factor that can act on other cell types.
Indeed Wislet-Gendebien et al.[43] have already demon-
strated that nestin-positive MSCs secrete BMP4, a member
of TGFβ family, which stimulates the astrocytic differenti-
ation of co-cultured neural stem cells, a maturation proc-
ess that involves a loss of nestin expression by these cells.
However, our co-culture experiments did not show any
significant decrease in the proportion of nestin-positive
MSCs when cells at a permissive density were grown with
other MSCs at higher densities in a setup that allows no
direct contact, suggesting rather a requirement for a direct
cell-to-cell contact for nestin repression. Alternatively,
high cellular density by increasing the direct cell-to-cell
contact in the culture dish could inhibit specifically the
proliferation of nestin-positive MSCs which then could
explain their decrease in number as the overall cellular
density increases.
During the last few years, a number of studies have
addressed the phenotypic plasticity of MSCs. Most of
these studies were performed in vivo and demonstrated
that environmental factors play important roles in deter-
mining the ability of grafted MSCs to adopt a neural-like
phenotype. Nakano et al. showed that murine bone mar-
row cells adopt a neural fate when they are directly
injected into the striatum of previously irradiated mice
[44]. Similarly, MSCs also adopt neural fate after systemic
injection in lethally irradiated mice [1]. Interestingly, the
systemic injection of MSCs in non-irradiated but brain-
lesioned mice had positive effects on injury repair, but
very few MSCs-derived cells expressed neural marker in
such conditions.
Conclusion
This work shows that the presence of thrombin in the cul-
ture medium stimulates the growth of both RG and MSCs
and that nestin expression by MSCs and RG can be regu-
lated in opposite manner by thrombin in vitro. Thrombin
effect is thus associated in both cell types with a prolifer-
ating, undifferentiated state but in RG this involves the
induction of nestin expression, a marker of immaturity forBMC Neuroscience 2007, 8:104 http://www.biomedcentral.com/1471-2202/8/104
Page 9 of 11
(page number not for citation purposes)
neural progenitors. In MSCs however, nestin expression,
as it corresponds to a progression from the mesenchymal
"undifferentiated", proliferating phenotype toward acqui-
sition of a neural fate, is inhibited by the mitogenic signal.
As we know that thrombin is expressed in the central nerv-
ous system [45] and is present in higher concentration
during brain injury and implicated in the response to
brain lesions [15], it will be interesting to study the effect
of thrombin on the regulation of the neural phenotypic
plasticity of MSCs in vivo in the context of their proposed
use as grafting material for cell therapeutic approaches of
the central nervous system lesions.
Methods
Preparation and culture of rat mesenchymal stem cells 
(MSCs)
Tissue used for preparing the cell cultures was obtained
from animals bred and kept in the University central ani-
mal facility in accordance with the rules set by the local
animal ethics committee. Adult rat MSCs were obtained
and cultivated as previously described [3,4,43]. After 25
cell population doublings in DEM/10% FBS (Invitrogen®,
Belgium), nestin expression was initiated by washing the
cultures with PBS and then growing them in DEM/F12
medium (Invitrogen®) at various densities (between 2,500
and 100,000 MSCs/cm2) on coverslips or in a T75-Flask.
Adult mouse bone marrow was obtained from femur and
tibias by aspiration and was resuspended into 5 ml of
DEM (Invitrogen®, Merelbeke, Belgium). About 10 × 107
marrow cells were plated on 25-cm2 tissue culture flask in
MesenCult Basal Media supplemented with MSC stimula-
tory supplements (StemCell Technologies®, Vancouver,
Canada). After 24 hours, the non-adherent cells were
removed by replacing the medium. When the mMSC
became confluent, they were resuspended with 0,25%
trypsin and 1 mM EDTA and then sub-cultured. To initiate
nestin expression, the culture were washed with PBS and
grown in DEM/F12 medium (Invitrogen®). After induc-
tion of nestin expression for 3 days, MSC plated at a den-
sity of 20,000 MSC/cm2  were transferred into DEM
supplemented with either 10% Foetal bovine serum
(FBS), different concentrations of thrombin (Calbio-
chem®, cat 605157, Belgium) or of TRAP6 (Bachem®, H-
8365, Belgium), 10-5 M FUdR (Sigma) or into MEM with
10% of horse serum. After 3 days, the cells on coverslips
were fixed or total proteins were extracted from the T75-
Flask. MSCs were then processed for immunocytofluores-
cence or Western blotting as described below.
Preparation and culture of Radial Glia (RG)
NMRI mice embryos were used. The day of conception
was determined by the presence of a vaginal plug (embry-
onic day 0). Dissociated cerebellar cells culture were pre-
pared from E16 or E17 embryos by digestion of minced
cerebella with 0.25% trypsin and 0.01% DNase 1 (Sigma®,
Belgium) for 22 min at 37°C, followed by trituration in a
flamed Pasteur pipette and filtration through a 40 μm
nylon mesh. Cells were then seeded as 50-μl drops con-
taining 125,000 cells on glass coverslips coated with 10
mg/ml polyornithine (Sigma®). After 30 min, the cells
were washed once with cold PBS to remove loosely adher-
ing neurons and 500 μl of growth medium (MEM con-
taining 6 g/l glucose and 10% horse serum Invitrogen®)
was added. This medium was changed every 2 days. For
experiments, RG cells were incubated in serum-free
medium during 48 hours and then treated in MEM sup-
plemented with serum or different concentration of
thrombin or TRAP6.
Immunocytofluorescence
The cultures were fixed with 4% (v/v) paraformaldehyde
for 15 minutes at room temperature and washed 3 times
in Tris-buffered saline (TBS) buffer. They were then per-
meabilized in 1% Triton-X100 (v/v) for 15 minutes and
washed 3 times in TBS buffer. Non-specific binding was
blocked by a 1 hour treatment in TBST (TBS buffer with
0.1% Tween-20) containing defatted milk powder (30
mg/ml). The cells were then incubated for 1 hour at room
temperature with anti-nestin (Rat401, mouse IgG,
Pharmingen®, Belgium, dilution 1:1500), anti-GFAP
(Mouse or rabbit IgG, Dako®, dilution 1:500) or anti-
PAR1 (H-111, rabbit IgG, BD Biosciences®, Belgium, dilu-
tion 1:250) diluted in blocking buffer. After 3 TBST
washes, cells were incubated in FITC- or Cy5-conjugated
anti-mouse IgG (Jackson Immunoresearch®, Belgium,
1:500) or rhodamine-conjugated anti-rabbit IgG (Jackson
Immunoresearch®,1:500) for 1 hour at room temperature
and in the dark. The nuclei were stained with 5 μM
TOPRO-3 iodide (Molecular Probes®, Belgium) and
mounted in Fluoprep (Biomerieux®, France) or with
vectashield hard set mounting medium with DAPI (Vector
laboratories®, Belgium). The preparations were then
observed using a Bio-Rad MRC1024 laser scanning confo-
cal microscope.
TUNEL assay
The cultures were fixed with 4% (v/v) paraformaldehyde
for 15 minutes at room temperature and washed 3 times
in Tris-buffered saline (TBS) buffer. They were then per-
meabilized in 1% Triton-X100 (v/v) with 0,1% sodium
citrate for 15 minutes and washed 3 times in TBS buffer.
Then, the presence of apoptotic cells was assayed with the
TUNEL label mix (Roche applied Science®, Belgium) fol-
lowing the manufacturer instructions.
Western Blot
Total protein extracts were obtained from confluent cells
that had been cultured in the different media. The cells
were harvested by scraping the dish in 500 μl lysis buffer
(0,6 M KCl, 5 mM EGTA, 5 mM EDTA, 1% Triton-X100BMC Neuroscience 2007, 8:104 http://www.biomedcentral.com/1471-2202/8/104
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and 1 mM PMSF in PBS). The cells were then fractioned
into pelletable (insoluble) and non-pelletable (soluble)
proteins by centrifugation at 30,000 × g for 15 minutes at
4°C. The pellet was suspended in electrophoresis loading
buffer (glycerol 20% v/v; SDS 2%; Tris 0,1 M pH 6,8 ; 5%
v/v β-mercaptoethanol; bromophenol blue) and the sus-
pension was centrifuged at 30,000 × g for 15 minutes at
4°C. The supernatant was used for protein concentration
measurement using the "RC DC Protein Assay" (Bio-Rad®,
Belgium). After normalization of protein contents, the
extracts were separated by electrophoresis on Phastgel
4–15% SDS gradient using the Phast System Instrument
(GE Healthcare®, Netherlands) and transferred to a PVDF
membrane using 25 mM Tris, 192 mM glycine and 20%
(V/V) methanol as blotting buffer. The membranes were
saturated with 3% gelatin (BioRad®), incubated for 1 hour
with the monoclonal antibody against rat nestin
(Pharmingen®, 1:1,000) or β-actin, (Sigma®, 1:5,000) at
room temperature and then washed several times with
TBST. The membrane was then incubated in biotinylated
goat anti-mouse antibody (Roche®, Brussels, Belgium;
1:5,000) for 1 h at room temperature. After several washes
in TBST, the membrane was incubated with peroxidase-
coupled streptavidin (1:100,000, Sigma®) at 37°C during
1 h. Signals were visualized with a solution of 0.01%
sodium perborate in 50 mM phosphate buffer containing
2% dioctyl sulfosuccinate (40 mg in 1 ml of dimethylfor-
mamide) and 2% 3-3'-5-5'-tetramethyl benzidine (20 mg
in 1 ml of dimethylformamide). Images were acquired
with the Magic Scan program and band intensities were
evaluated with Image Master 1D Elite.
Reverse transcription-polymerase chain reaction (RT-
PCR) analysis
Total RNA of rat MSCs and mouse RG cells were isolated
with the RNeasy Midi Kit (Qiagen®, Belgium) as described
in the protocol of the manufacturer, and treated with
RNAse-free DNAse to remove any possible contamination
by genomic DNA. As determined by 260/280 OD read-
ings, 1 μg of total RNA was reverse-transcribed using prim-
ers with oligodT and 200 U of reverse transcriptase
(Superscript, Invitrogen®). A 2 μl aliquot of the resulting
cDNA reaction, used as template, was added to a 50 μl
PCR reaction mixture containing: 0.2 μM of both forward
and reverse primers synthesized by Eurogentec®  (Bel-
gium), 0.2 mM of each dNTP, 1.5 mM of MgCl2 and 5 U
of Taq polymerase (Promega®, The Netherlands). The PCR
program was achieved in a PTC 200 instrument (MJ
Research®, USA). After a 2 min denaturation step at 94°C,
amplifications were carried out for 35 cycles (94°C for 1
min, 55°C for 1 min and 72°C for 1 min), followed by a
final extension at 72°C for 1 min. Ten microlitres of the
PCR reaction was analysed in a 3% agarose gel in tris-ace-
tic acid-EDTA (TAE) buffer. The primers used in PCR reac-
tion for PAR1 are 5'-TGA CAG TCA TAA GCA TTG AC-3'
for the rat forward primer and 5'-GGC ATA GTA GTA AAT
CAA GG-3' for the rat reverse primer, 5'-TAT-CCG-ATC-
CAG-TCC-CTG-TC-3' for the mouse forward primer and
5'-AGA-CCG-TGG-AAA-CGA-TCA-AC-3' for the mouse
reverse primer. The annealing temperature for mouse
PAR1 PCR was set at 58°C. For rat GAPDH, the primers
used in PCR reaction were 5'-GAC CCC TTC ATT GAC
CTC AAC TAC ATG-3' for the forward primer and 5'-GCC
TTC TCC ATG GTG GTG AAC AC-3' for the reverse primer.
BrdU incorporation assay
After 3 days of culture in serum free medium, bromodeox-
yuridine (BrdU) (20 μM, Sigma®) was added to RG and
MSCs cultures (cultivated in serum- or thrombin- contain-
ing medium) for 18 hours before fixation with parafor-
maldehyde and immunofluorescent staining. For BrdU
labelling after nestin immunolabelling performed as
described above, coverslips were post-fixed for 10 minutes
in 4% (v:v) paraformaldehyde, incubated in HCl 1 N for
20 minutes at 37°C, washed with sodium borate solution
(50 mM, pH 8.5) and finally incubated with anti-BrdU
antibody for 1 hour at room temperature (Oxford Bio-
technology®, rat IgG, dilution 1:200) and Cy-5-conjugated
anti-rat antibody, 1 hour at room temperature. The prep-
arations were observed as described above.
Cell counting and statistical analysis
For each condition 2 coverslips per culture and 10 micro-
scopic fields (40×)/coverslip were counted for three sepa-
rate cultures. Statistical analyses were performed using an
ANOVA-1 test and Dunnett post-test.
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